Whales with a lot of money to spend have taken a noticeably bullish stance on Pfizer.
Looking at options history for Pfizer PFE we detected 15 trades.
If we consider the specifics of each trade, it is accurate to state that 53% of the investors opened trades with bullish expectations and 26% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $345,963 and 12, calls, for a total amount of $1,524,951.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $30.0 for Pfizer over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Pfizer’s options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pfizer’s whale trades within a strike price range from $20.0 to $30.0 in the last 30 days.
Pfizer Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PFE | CALL | SWEEP | BULLISH | 02/21/25 | $0.98 | $0.93 | $0.98 | $25.00 | $245.0K | 5.8K | 2.5K |
| PFE | CALL | SWEEP | BULLISH | 02/21/25 | $0.98 | $0.98 | $0.98 | $25.00 | $232.7K | 5.8K | 2.4K |
| PFE | PUT | TRADE | BULLISH | 08/15/25 | $1.6 | $1.53 | $1.53 | $25.00 | $229.5K | 4.4K | 13 |
| PFE | CALL | SWEEP | BULLISH | 02/21/25 | $1.0 | $0.85 | $1.0 | $25.00 | $217.7K | 5.8K | 9.6K |
| PFE | CALL | SWEEP | NEUTRAL | 09/19/25 | $3.55 | $3.5 | $3.5 | $23.00 | $175.5K | 680 | 500 |
About Pfizer
Pfizer is one of the world’s largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
In light of the recent options history for Pfizer, it’s now appropriate to focus on the company itself. We aim to explore its current performance.
Current Position of Pfizer
- Currently trading with a volume of 22,984,668, the PFE’s price is down by -1.26%, now at $25.55.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 78 days.
What The Experts Say On Pfizer
In the last month, 2 experts released ratings on this stock with an average target price of $31.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge’s Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
* An analyst from Guggenheim downgraded its action to Buy with a price target of $33.
* Consistent in their evaluation, an analyst from Citigroup keeps a Neutral rating on Pfizer with a target price of $29.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Pfizer, Benzinga Pro gives you real-time options trades alerts.
Overview Rating:
Speculative
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
